Latest / Cleveland Clinic Cancer Advances
Discoveries in CAEL-101 Trial for Patients with AL Amyloidosis
Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.